Skip to search formSkip to main contentSkip to account menu

glyceryl 2-arachidonate

Known as: 2-arachidonyl-glycerol, 5,8,11,14-eicosatetraenoic acid, 2-hydroxy-1-(hydroxymethyl)ethyl ester, (all-Z)-, 2-arachidonylglycerol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
As the incidence of obesity continues to increase, the development of effective therapies is a high priority. The endocannabinoid… 
Review
2007
Review
2007
The specific protein target of delta9-tetrahydrocannabinol (delta9-THC), the main active ingredient of Cannabis sativa L., was… 
Highly Cited
2006
Highly Cited
2006
We used a model of neuropathic pain consisting of rats with chronic constriction injury (CCI) of the sciatic nerve, in order to… 
Highly Cited
2005
Highly Cited
2005
As persistent behavioural changes, such as increased anxiety-related behaviours, can be predicted based on the phenomenon of… 
Highly Cited
2004
Highly Cited
2004
The effects of endogenous and synthetic cannabinoid receptor agonists including 2-arachidonoylglycerol, R-methanandamide, WIN55… 
Highly Cited
2003
Highly Cited
2003
At nanomolar concentrations, SR141716 and AM251 act as specific and selective antagonists of the cannabinoid CB1 receptor. In the… 
Review
2002
Review
2002
Anandamide (N -arachidonoylethanolamine) was the first ligand to be identified as an endogenous ligand of the G-protein coupled… 
Highly Cited
2001
Highly Cited
2001
The endocannabinoid signaling system is believed to play a down‐regulatory role in the control of cell functions. However, little… 
Highly Cited
2001
Highly Cited
2001
The endocannabinoid, 2-arachidonylglycerol (2-AG), is an endogenous ligand for the central (CB1) and peripheral (CB2) cannabinoid…